Theravance Biopharma, Inc. (TBPH)

Last Three Months

24-Jan-24 -- 23-Apr-24

Time Period:

Three Months
|
Year

($10.92K) Net Amount

Buy:	0	--
Sell:	($10.92K)	$8.71

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

29

0

4

+1

0

+2

0

+3

Two Year Chart

24-Apr-22 -- 23-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
04-Apr-24 6:17 PM View:	02-Apr-24 Grant 0	Winningham Rick E Chief Executive Officer Director		Theravance Biopharma, Inc. - TBPH	15% 1.69M to 1.95M	0	0	--	--	Show Txns Hide Txns

04-Apr-24 6:09 PM View:	02-Apr-24 Grant 0	Farnum Rhonda SVP, Comm & Medical Affairs		Theravance Biopharma, Inc. - TBPH	5% 331.21K to 349.23K	0	($10.92K)	--	$8.71	Show Txns Hide Txns

22-Feb-24 8:06 PM View:	20-Feb-24 Payment of Exercise ($172.10K)	Graham Richard A SVP, RESEARCH & DEVELOPMENT		Theravance Biopharma, Inc. - TBPH	(6%) 334.21K to 314.92K	0	0	--	--	Show Txns Hide Txns

04-Apr-24 6:15 PM View:	02-Apr-24 Grant 0	Sawaf Aziz SVP & Chief Financial Officer		Theravance Biopharma, Inc. - TBPH	32% 255.67K to 338.64K	0	0	--	--	Show Txns Hide Txns

04-Apr-24 6:11 PM View:	02-Apr-24 Grant 0	Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY		Theravance Biopharma, Inc. - TBPH	30% 278.28K to 360.68K	0	0	--	--	Show Txns Hide Txns

04-Apr-24 6:13 PM View:	02-Apr-24 Grant 0	Miller Aine SVP, Dev & Head of IRE Office		Theravance Biopharma, Inc. - TBPH	18% 145.32K to 171.03K	0	0	--	--	Show Txns Hide Txns